Aurora Cannabis Inc T.ACB

Alternate Symbol(s): ACB | T.ACB.WS.U

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by MrPumpandDump1on Jan 04, 2018 8:43am

135 Views

Post# 27278375

RE:RE:Capacity utilization rate

Pure Fluff news and these pumpers cheer about nothing and sheep run to slaughter

clayface wrote:
Braincells13 wrote: I am stunned that almost everybody here thinks that any weed company will be able to have a capacity utilization rate of 100%. Novice investors and speculators jump in when they see news mentionning any capacity expansion, but they don't ask themselves whether this additional capacity is worth it (i.e. if the company will be able to sell everything they produce). Capacity utilization rate for Tobacco companies is about 55% to 65%. There are so many weed companies out there, I wouldn't be surprised to see a lower rate for weed companies. Truth is weed companies will not have the upper hand in their negociations with resellers, offer will be significantly higher than demand, resulting in a lower sale price to resellers.

With this post, some blind people/pumpers/etc. will accuse me of trying to "scare" investors. This is not my objective. I am just trying to help investors with limited experience to conduct a proper due diligence and properly identify and assess the risks.

Full disclosure: I am long puts.

Man’s how convenient this came out when they need to raise the sp to buy CMED. This is fluff. With a percentage owned already with the Pedonis. I already assumed that they would expand and that this should be factored in the sp already. New investors are clueless on investing...paying more for what should and is already factored into the sp at $5.00